277 related articles for article (PubMed ID: 33558705)
1. USP9X-mediated KDM4C deubiquitination promotes lung cancer radioresistance by epigenetically inducing TGF-β2 transcription.
Jie X; Fong WP; Zhou R; Zhao Y; Zhao Y; Meng R; Zhang S; Dong X; Zhang T; Yang K; Wu G; Xu S
Cell Death Differ; 2021 Jul; 28(7):2095-2111. PubMed ID: 33558705
[TBL] [Abstract][Full Text] [Related]
2. USP9X-mediated REV1 deubiquitination promotes lung cancer radioresistance via the action of REV1 as a Rad18 molecular scaffold for cystathionine γ-lyase.
Chen Y; Feng X; Wu Z; Yang Y; Rao X; Meng R; Zhang S; Dong X; Xu S; Wu G; Jie X
J Biomed Sci; 2024 May; 31(1):55. PubMed ID: 38802791
[TBL] [Abstract][Full Text] [Related]
3. Targeting KDM4C enhances CD8
Jie X; Chen Y; Zhao Y; Yang X; Xu Y; Wang J; Meng R; Zhang S; Dong X; Zhang T; Yang K; Xu S; Wu G
J Immunother Cancer; 2022 Feb; 10(2):. PubMed ID: 35121645
[TBL] [Abstract][Full Text] [Related]
4. UBE2O targets Mxi1 for ubiquitination and degradation to promote lung cancer progression and radioresistance.
Huang Y; Yang X; Lu Y; Zhao Y; Meng R; Zhang S; Dong X; Xu S; Wu G
Cell Death Differ; 2021 Feb; 28(2):671-684. PubMed ID: 32901121
[TBL] [Abstract][Full Text] [Related]
5. Wnt-Induced Stabilization of KDM4C Is Required for Wnt/β-Catenin Target Gene Expression and Glioblastoma Tumorigenesis.
Chen Y; Fang R; Yue C; Chang G; Li P; Guo Q; Wang J; Zhou A; Zhang S; Fuller GN; Shi X; Huang S
Cancer Res; 2020 Mar; 80(5):1049-1063. PubMed ID: 31888886
[TBL] [Abstract][Full Text] [Related]
6. The evolutionarily conserved deubiquitinase UBH1/UCH-L1 augments DAF7/TGF-β signaling, inhibits dauer larva formation, and enhances lung tumorigenesis.
Nagata A; Itoh F; Sasho A; Sugita K; Suzuki R; Hinata H; Shimoda Y; Suzuki E; Maemoto Y; Inagawa T; Fujikawa Y; Ikeda E; Fujii C; Inoue H
J Biol Chem; 2020 Jul; 295(27):9105-9120. PubMed ID: 32371398
[TBL] [Abstract][Full Text] [Related]
7. Histone demethylase KDM4C controls tumorigenesis of glioblastoma by epigenetically regulating p53 and c-Myc.
Lee DH; Kim GW; Yoo J; Lee SW; Jeon YH; Kim SY; Kang HG; Kim DH; Chun KH; Choi J; Kwon SH
Cell Death Dis; 2021 Jan; 12(1):89. PubMed ID: 33462212
[TBL] [Abstract][Full Text] [Related]
8. Deubiquitinase USP9X deubiquitinates β-catenin and promotes high grade glioma cell growth.
Yang B; Zhang S; Wang Z; Yang C; Ouyang W; Zhou F; Zhou Y; Xie C
Oncotarget; 2016 Nov; 7(48):79515-79525. PubMed ID: 27783990
[TBL] [Abstract][Full Text] [Related]
9. OTUB1 Targets CHK1 for Deubiquitination and Stabilization to Facilitate Lung Cancer Progression and Radioresistance.
Wang J; Liu Y; Wu D; Tian C; Gao J; Yang Q; Hong X; Gu F; Zhang K; Hu Y; Xu S; Liu L; Zeng Y
Int J Radiat Oncol Biol Phys; 2024 Jul; 119(4):1222-1233. PubMed ID: 38266782
[TBL] [Abstract][Full Text] [Related]
10. β-Trcp ubiquitin ligase and RSK2 kinase-mediated degradation of FOXN2 promotes tumorigenesis and radioresistance in lung cancer.
Ma J; Lu Y; Zhang S; Li Y; Huang J; Yin Z; Ren J; Huang K; Liu L; Yang K; Wu G; Xu S
Cell Death Differ; 2018 Aug; 25(8):1473-1485. PubMed ID: 29396548
[TBL] [Abstract][Full Text] [Related]
11. Histone demethylase KDM4C regulates sphere formation by mediating the cross talk between Wnt and Notch pathways in colonic cancer cells.
Yamamoto S; Tateishi K; Kudo Y; Yamamoto K; Isagawa T; Nagae G; Nakatsuka T; Asaoka Y; Ijichi H; Hirata Y; Otsuka M; Ikenoue T; Aburatani H; Omata M; Koike K
Carcinogenesis; 2013 Oct; 34(10):2380-8. PubMed ID: 23698634
[TBL] [Abstract][Full Text] [Related]
12. A novel USP9X substrate TTK contributes to tumorigenesis in non-small-cell lung cancer.
Chen X; Yu C; Gao J; Zhu H; Cui B; Zhang T; Zhou Y; Liu Q; He H; Xiao R; Huang R; Xie H; Gao D; Zhou H
Theranostics; 2018; 8(9):2348-2360. PubMed ID: 29721084
[TBL] [Abstract][Full Text] [Related]
13. USP9X deubiquitinates and stabilizes CDC123 to promote breast carcinogenesis through regulating cell cycle.
Song N; Deng L; Zeng L; He L; Liu C; Liu L; Fu R
Mol Carcinog; 2023 Oct; 62(10):1487-1503. PubMed ID: 37314216
[TBL] [Abstract][Full Text] [Related]
14. KDM4C and ATF4 Cooperate in Transcriptional Control of Amino Acid Metabolism.
Zhao E; Ding J; Xia Y; Liu M; Ye B; Choi JH; Yan C; Dong Z; Huang S; Zha Y; Yang L; Cui H; Ding HF
Cell Rep; 2016 Jan; 14(3):506-519. PubMed ID: 26774480
[TBL] [Abstract][Full Text] [Related]
15. Deubiquitylase USP9X suppresses tumorigenesis by stabilizing large tumor suppressor kinase 2 (LATS2) in the Hippo pathway.
Zhu C; Ji X; Zhang H; Zhou Q; Cao X; Tang M; Si Y; Yan H; Li L; Liang T; Feng XH; Zhao B
J Biol Chem; 2018 Jan; 293(4):1178-1191. PubMed ID: 29183995
[TBL] [Abstract][Full Text] [Related]
16. Deubiquitinase USP9x confers radioresistance through stabilization of Mcl-1.
Trivigno D; Essmann F; Huber SM; Rudner J
Neoplasia; 2012 Oct; 14(10):893-904. PubMed ID: 23097624
[TBL] [Abstract][Full Text] [Related]
17. Opposing Chromatin Signals Direct and Regulate the Activity of Lysine Demethylase 4C (KDM4C).
Pack LR; Yamamoto KR; Fujimori DG
J Biol Chem; 2016 Mar; 291(12):6060-70. PubMed ID: 26747609
[TBL] [Abstract][Full Text] [Related]
18. Cyclin K interacts with β-catenin to induce Cyclin D1 expression and facilitates tumorigenesis and radioresistance in lung cancer.
Yao G; Tang J; Yang X; Zhao Y; Zhou R; Meng R; Zhang S; Dong X; Zhang T; Yang K; Wu G; Xu S
Theranostics; 2020; 10(24):11144-11158. PubMed ID: 33042275
[No Abstract] [Full Text] [Related]
19. ATM-mediated stabilization of ZEB1 promotes DNA damage response and radioresistance through CHK1.
Zhang P; Wei Y; Wang L; Debeb BG; Yuan Y; Zhang J; Yuan J; Wang M; Chen D; Sun Y; Woodward WA; Liu Y; Dean DC; Liang H; Hu Y; Ang KK; Hung MC; Chen J; Ma L
Nat Cell Biol; 2014 Sep; 16(9):864-75. PubMed ID: 25086746
[TBL] [Abstract][Full Text] [Related]
20. IQGAP3 interacts with Rad17 to recruit the Mre11-Rad50-Nbs1 complex and contributes to radioresistance in lung cancer.
Zeng Y; Jie X; Wu B; Wu G; Liu L; Xu S
Cancer Lett; 2020 Nov; 493():254-265. PubMed ID: 32896617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
